EUVIMEDEUVIMED entdecken
Crossref

Correlation Between Serum and CSF Concentrations of Midazolam and 1-Hydroxy-Midazolam in Critically Ill Neurosurgical Patients

Julie E Farrar iD, Sylvia S Stefanos, Luis Cava, Tyree H Kiser, Scott W Mueller, Robert Neumann, Paul M Reynolds, Deb S Sherman, Robert MacLaren iD

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280241271130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Julie E Farrar und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, The University of Tennessee, Memphis, TN, USA. Hauptthemen laut MEDLINE: Midazolam, Hypnotics and Sedatives, Neurosurgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Midazolam (MZ) is commonly used in critically ill neurosurgical patients. Neuro-penetration of MZ and its metabolite, 1-hydroxy-midazolam (1-OH-MZ), is not well characterized.

Objective

This study evaluated correlations between serum and cerebrospinal fluid (CSF) concentrations of MZ and 1-OH-MZ and assessed implications on patient sedation.

Methods

Adults in the neurosurgical intensive care unit (ICU) with external ventricular drains receiving MZ via continuous infusion were prospectively studied. Serum and CSF samples were obtained 12-24 h and 72-96 h after initiation, and concentrations were determined in duplicate by high-performance liquid chromatography with tandem mass spectrometry. Bivariate correlation analyses used Pearson coefficient.

Results

A total of 31 serum and CSF samples were obtained from 18 subjects. At sampling, mean MZ infusion rate was 3.9 ± 4.4 mg/h, and previous 12-h cumulative dose was 51.4 ± 78.2 mg. Mean concentrations of MZ and 1-OH-MZ in serum and CSF were similar between timepoints. Similarly, ratios of 1-OH-MZ to MZ in serum and CSF remained stable over time. Serum MZ (126.2 ± 89.3 ng/mL) showed moderate correlation (r 2 = 0.68, P < 0.001) with serum 1-OH-MZ (17.7 ± 17.6 ng/mL) but not CSF MZ (3.9 ± 2.5 ng/mL; r 2 = 0.24, P = 0.005) or CSF 1-OH-MZ (2.5 ± 0.6 ng/mL; r 2 = 0.47, P = 0.30). CSF MZ did not correlate with CSF 1-OH-MZ (r 2 = 0.003, P < 0.001). Mean serum ratio of 1-OH-MZ to MZ (0.14 ± 0.2 ng/mL) did not correlate with CSF ratio (1.06 ± 0.83 ng/mL; r 2 = 0.06, P = 0.19). Concentrations and ratios were unrelated to MZ infusion rate or 12-h cumulative dose. Sedation was weakly correlated with CSF 1-OH-MZ, but not with serum MZ, serum 1-OH-MZ, or CSF MZ. Conclusion and Relevance: Continuous infusions of MZ result in measurable concentrations of MZ and 1-OH-MZ in CSF; however, CSF concentrations of MZ and 1-OH-MZ poorly represent serum concentrations or dosages. Accumulation of MZ and 1-OH-MZ in serum or CSF over time was not evident. Concentrations of MZ and 1-OH-MZ do not predict sedation levels, reinforcing that pharmacodynamic assessments are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MidazolamHypnotics and SedativesNeurosurgical ProceduresHumansCritical IllnessMaleFemaleMiddle AgedProspective StudiesAgedAdultIntensive Care UnitsTandem Mass SpectrometryChromatography, High Pressure Liquid

Stichwörter der Autor:innen

cerebrospinal fluidcritical caremidazolamneurosurgery

Substanzen

MidazolamHypnotics and Sedatives1-hydroxymethylmidazolam

Autor:innen und Institutionen

  • College of Pharmacy, The University of Tennessee, Memphis, TN, USA.
  • Houston Methodist Hospital, Houston, TX, USA.
  • School of Medicine, University of Colorado, Aurora, CO, USA.
  • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA.
  • University of Colorado Hospital, Aurora, CO, USA.
  • Rocky Mountain Regional VA Medical Center, Denver, CO, USA.

ORCID-Profile: Julie E Farrar, Robert MacLaren

Zitieren

APA

Farrar, J. E., Stefanos, S. S., Cava, L., Kiser, T. H., Mueller, S. W., Neumann, R., Reynolds, P. M., Sherman, D. S., & MacLaren, R. (2025). Correlation Between Serum and CSF Concentrations of Midazolam and 1-Hydroxy-Midazolam in Critically Ill Neurosurgical Patients. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280241271130

Vancouver

Farrar JE, Stefanos SS, Cava L, Kiser TH, Mueller SW, Neumann R, et al. Correlation Between Serum and CSF Concentrations of Midazolam and 1-Hydroxy-Midazolam in Critically Ill Neurosurgical Patients. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280241271130

BibTeX
@article{Farrar2025,
  author = {Farrar, Julie E and Stefanos, Sylvia S and Cava, Luis and Kiser, Tyree H and Mueller, Scott W and Neumann, Robert and Reynolds, Paul M and Sherman, Deb S and MacLaren, Robert},
  title = {Correlation Between Serum and CSF Concentrations of Midazolam and 1-Hydroxy-Midazolam in Critically Ill Neurosurgical Patients},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280241271130}
}
Kostenlos starten →